Georgia's Online Cancer Information Center

Mary Alice Moses: “[I wanted to] increase the number of women who participated in clinical trials.” MaryAlice Moses

Mary Alice Moses

“[I wanted to] increase the number of women who participated in clinical trials.”

When Austell, Ga resident MaryAlice Moses was notified of an opportunity to participate in two cancer prevention clinical trials, she knew it was the right thing to do.

Even though MaryAlice did not have cancer, she wanted a chance to contribute to cancer research. She was aware that the clinical trials presented to her would be used to identify risk factors for developing breast and ovarian cancers.

So, MaryAlice decided to enroll in both "The Sister Study: A Study of the Environmental and Genetic Risk Factors for Breast Cancer" and in the "North Carolina Ovarian Cancer Study." These studies involve individuals who have cancer as well as those who have never had cancer – all to help determine the factors that put a person at higher risk for developing a certain type of cancer.

MaryAlice admits, she was at first skeptical about the intent of clinical trials.

So she conducted some research of her own to learn about the meaning and purposes of clinical trials. Once she learned about their significance in the cancer community, her attitude changed.

MaryAlice states that she got involved with clinical trials in order to "assist in the findings regarding data on African American women and to increase the number of women who participate in clinical trials."

Back to Survivors' Voices

Cancer Survivorship Connection

Guest Editorial: A three-time cancer survivor should not get COVID-19, but I did

Cancer patients and survivors should not get COVID-19. A three-time cancer survivor should definitely not get COVID. But I did. And it was not good. Here is my story and the lessons I learned that might be of value to others.


Survivors helping others survive

Three women, three cancer survivorship journeys, three missions resulting in nonprofits started to help and support others fighting cancer.


Despite pandemic, Georgia’s Colorectal Cancer Control Program making significant strides

Thanks to funding awarded by the Centers for Disease Control for five-years beginning July 2020, Georgia CORE and Augusta University are partners in the Georgia Colorectal Cancer Control Program, which is increasing CRC screenings in southeast and southwest Georgia.


Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.